DNA Analysis of Tissue From Patients With T-Cell Acute Lymphoblastic Leukemia

Sponsor
ECOG-ACRIN Cancer Research Group (Other)
Overall Status
Completed
CT.gov ID
NCT00899366
Collaborator
National Cancer Institute (NCI) (NIH)
49
31

Study Details

Study Description

Brief Summary

RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This laboratory study is looking at tissue samples from patients with T-cell acute lymphoblastic leukemia.

Condition or Disease Intervention/Treatment Phase
  • Genetic: microarray analysis
  • Genetic: mutation analysis
  • Other: immunologic technique

Detailed Description

OBJECTIVES:
  • Identify the transcriptional signatures associated with the presence of NOTCH1 mutations in primary T-cell acute lymphoblastic leukemia (T-ALL) cells using oligonucleotide microarrays.

  • Characterize the global changes on gene expression resulting from the inactivation of NOTCH signaling in human T-ALL lymphoblasts.

OUTLINE: This is a multicenter study.

Frozen lymphoblast samples from patients with T-cell acute lymphoblastic leukemia (NOTCH1-mutated and wild type) are assessed for genetic expression profiles and mutations by microarray analysis and activated NOTCH1 protein by western blot analysis.

PROJECTED ACCRUAL: A total of 48 samples from patients will be accrued for this study.

Study Design

Study Type:
Observational
Actual Enrollment :
49 participants
Observational Model:
Other
Time Perspective:
Retrospective
Official Title:
Molecular Mechanisms of NOTCH Induced Transformation in T-ALL
Actual Study Start Date :
Dec 28, 2006
Actual Primary Completion Date :
Jul 30, 2009
Actual Study Completion Date :
Jul 30, 2009

Outcome Measures

Primary Outcome Measures

  1. Transcriptional signatures associated with NOTCH1 mutations in T-cell acute lymphoblastic leukemia (T-ALL) cells [1 month]

    Mutational analysis

  2. Global changes on gene expression resulting from inactivation of NOTCH signaling in T-ALL cells [1 month]

    Gene expression

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 120 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
DISEASE CHARACTERISTICS:
  • Confirmed diagnosis of T-cell acute lymphoblastic leukemia

  • Frozen lymphoblast samples available

  • NOTCH1-mutated or wild type sample available

PATIENT CHARACTERISTICS:
  • Not specified
PRIOR CONCURRENT THERAPY:
  • Not specified
Exclusion Criteria:
  • Not applicable

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • ECOG-ACRIN Cancer Research Group
  • National Cancer Institute (NCI)

Investigators

  • Study Chair: Adolfo A. Ferrando, MD, PhD, Herbert Irving Comprehensive Cancer Center

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
ECOG-ACRIN Cancer Research Group
ClinicalTrials.gov Identifier:
NCT00899366
Other Study ID Numbers:
  • CDR0000529758
  • ECOG-E2993T2
  • R01CA129382
First Posted:
May 12, 2009
Last Update Posted:
Feb 5, 2020
Last Verified:
May 1, 2017

Study Results

No Results Posted as of Feb 5, 2020